...
首页> 外文期刊>Current Organic Synthesis >Vitrified Human Umbilical Arteries as Potential Grafts for Vascular Tissue Engineering
【24h】

Vitrified Human Umbilical Arteries as Potential Grafts for Vascular Tissue Engineering

机译:玻璃化人脐动脉作为血管组织工程的潜在移植物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background The development of a biological based small diameter vascular graft (d < 6 mm), that can be properly stored over a long time period at - 196 degrees C, in order to directly be used to the patients, still remains a challenge. In this study the decellularized umbilical arteries (UAs) where vitrified, evaluated their composition and implanted to a porcine model, thus serving as vascular graft. Methods Human UAs were decellularized using 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) and sodium dodecyl sulfate (SDS) detergents. Then, vitrified with vitrification solution 55 (VS55) solution, remained for 6 months in liquid nitrogen and their extracellular matrix composition was compared to conventionally cryopreserved UAs. Additionally, total hydroxyproline, sulphated glycosaminoglycan and DNA content were quantified in all samples. Finally, the vitrified umbilical arteries implanted as common carotid artery interposition graft to a porcine animal model. Results Decellularized and vitrified UAs characterized by proper preservation of extracellular matrix proteins and tissue architecture, whereas conventionally cryopreserved samples exhibited a disorganized structure. Total hydroxyproline content was preserved, although sulphated glycosaminoglycan and DNA contents presented significantly alterations in all samples. Implanted UAs successfully recellularized and remodeled as indicated by the histological analysis. Conclusion Decellularized and vitrified UAs retained their structure function properties and can be possible used as an alternative source for readily accessible small diameter vascular grafts.
机译:背景技术生物学的小直径血管移植物(D <6mm)的发展,可以在长时间内储存在196℃的长时间内,以便直接用于患者,仍然是一个挑战。在该研究中,在玻璃化,评估它们的组合物并注入猪模型的脱细胞的脐动脉(UA),从而用作血管移植物。方法使用3 - [(3-胆氨酰氨基丙基)二甲基氨基乙基甲基氨基甲基(CHAPS)和十二烷基硫酸钠(SDS)洗涤剂,人UA脱细胞脱细胞。然后,用玻璃化溶液55(Vs55)溶液玻璃化在液氮中保持6个月,将其细胞外基质组合物与常规冷冻保存的UA进行比较。另外,在所有样品中定量总羟脯氨酸,硫酸化糖胺聚糖和DNA含量。最后,植入植入猪动物模型的常见颈动脉插入移植物的玻璃化脐动脉。结果脱细胞和玻璃化UA,其特征在于适当保存细胞外基质蛋白和组织结构,而常规冷冻保存样品表现出杂化结构。保留了总羟脯氨酸含量,尽管硫酸化糖胺聚糖和DNA含量在所有样品中显着改变。植入的UA成功经过细微化并改造,如组织学分析所示。结论脱细胞和玻璃化UA保留了它们的结构功能性能,可以用作易于可接近的小直径血管移植物的替代源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号